Trademarkia Logo

Canada

C$
Trademark Search in Canada
SPYBIOTECH

View On IC.GC.CA

SPYBIOTECH
ADVERTISED

on 5 Feb 2025

Last Applicant/ Owned by

SPYBIOTECH LIMITED

7600 The Quorum, Alec Issigonis Way,Oxford Business Park NorthOXFORD OX4 2JZ

GB

Serial Number

2140135 filed on 18th Aug 2021

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 16001 FIRST CANADIAN PLACE100 KING STREET WESTTORONTO

ONTARIO

CA

M5X1G5

SPYBIOTECH

Trademark usage description

pharmaceutical, biopharmaceutical and medicinal human and veterinary vaccine preparations and substances; biological, chemical and biochemical therape Read More

Classification Information

Class [001]
Chemical, biochemical and biological reagents for scientific, laboratory and medical research use, namely, for the manufacture of human and veterinary vaccines, chemical vaccine reagents for medical-scientific research purposes, molecular biology research tools in the nature of chemical, biochemical and biological vaccine reagents for medical-scientific research use, biological and chemical vaccine reagents for medical-scientific research, clinical chemistry, and commercial use, chemical, biochemical and biological reagents for use in the manufacture of human and veterinary vaccines, none being for medical and veterinary purposes

Classification kind code

11

Class [005]
Pharmaceutical, biopharmaceutical and medicinal human and veterinary vaccine preparations and substances; biological, chemical and biochemical therapeutic reagents for medical use for the prevention and treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, dementia and Parkinson's disease, chronic diseases, namely chronic liver disease, chronic pain, chronic inflammation, respiratory diseases, metabolic syndrome, genetic conditions, cancer, cardiovascular diseases and prevention and treatment of infectious diseases with antiviral, antibacterial, antifungal, and antiparasitic human and veterinary vaccine preparations; human and veterinary vaccines; biological preparations for medical purposes, namely, for the prevention and treatment of ophthalmological conditions, hematologic diseases, immune response disorders, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, dementia and Parkinson's disease, chronic diseases, namely chronic liver disease, chronic pain, chronic inflammation, respiratory diseases, metabolic syndrome, genetic conditions, cancer, cardiovascular diseases and prevention and treatment of infectious diseases with antiviral, antibacterial, antifungal, and antiparasitic human and veterinary vaccine preparations; human and veterinary vaccine preparations

Classification kind code

11

Class [042]
Medical and pharmaceutical research services, biological therapeutic research, development of pharmaceutical preparations and medicines, research and development relating to biologic therapeutic preparations and vaccines, providing medical and scientific research information in the field of pharmaceuticals and vaccines, clinical trials, clinical trial design for vaccines, software as a service (SaaS) provided for accessing medical and health information, programming of software for internet platforms, namely, a bioinformatics platform for manufacturing therapeutics, scientific services, namely, the discovery, preclinical and clinical product development of vaccines and biological therapeutic products, research and development of new products for others, development of pharmaceutical products for others, information, advisory and consultancy services for the aforesaid

Classification kind code

11

Mark Details

Serial Number

2140135

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 17th Feb 2023		Agent Changed
Submitted for opposition 22
on 19th Jan 2023		Search Recorded
Submitted for opposition 20
on 19th Jan 2023		Examiner's First Report
Submitted for opposition 223
on 19th Jan 2023		Total Provisional Refusal
Submitted for opposition 256
on 15th Aug 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 14th Oct 2021		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 14th Oct 2021		Formalized
Submitted for opposition 1
on 14th Oct 2021		Created
Submitted for opposition 228
on 18th Aug 2021		International Registration
Submitted for opposition 30
on 18th Aug 2021		Filed